Mats Holmquist, PhD, Assoc Prof
CEO, Co-founder : Strategic R&D leadership for the next stage of growth
Mats brings more than 30 years of experience in research and development leadership, including 18 years at BioArctic AB. During that time, he served on the management team and scientific board, contributing to the company’s development from an agile start-up into a profitable Nasdaq Stockholm-listed organisation with approximately 200 employees. His experience includes the development journey of Leqembi® (lecanemab), from early discovery through clinical development to patients worldwide. This gives Mats a rare perspective on the scientific, technical, regulatory and organisational work required to build a programme and a company over the long term.
Mats understanding of the startup journey is rooted in hands-on experience. Early in his career, he was part of the rapid growth of Gyros Protein Technologies AB—a spin-off from Amersham Pharmacia Biotech—as it scaled from 30 to over 100 employees. Working as a Project Manager and Senior Scientist, he worked closely across teams integrating the development of hardware, software, CD consumables, and applications, while actively supporting the product launches of the developed Gyrolab® technology and Gyrolab® discs, by presentations to Big Pharma at international conferences. Being part of that journey taught him what it takes to bring novel innovative technologies and products to market.
Alongside his extensive industry experience, Mats also bring a solid understanding of the academic research landscapes and conditions, as an Affiliated Associate Professor in Biochemistry (Docent) at the Royal Intitute of Technology in Stockholm for more than 25 years.
Today, he advises start-up, early-stage and growing life-science companies as they prepare for critical development milestones, technical scale-up and organizational growth. He helps leadership teams make robust decisions in areas where scientific opportunity, operational capability and business value need to align. The aim is not simply to add processes, meetings or impressive-looking arrows to a slide; it is to create the right level of structure for progress.
Mats is known for combining scientific depth with clear strategic thinking and a pragmatic leadership style. He supports teams in addressing both the immediate decision in front of them and the capabilities they will need for the next stage of growth.
Areas of support
Strategic R&D leadership and scale-up of teams and organisations
Preclinical and clinical development strategy
Biotechnology, CMC and technical development assessment
CMC strategy, GMP readiness and external manufacturing partnerships
Scientific, regulatory and technical due diligence
Non-dilutive funding, grant strategy and application review
Board, investor and partner communication
Building practical decision-making structures for growing R&D organisations
#BiotechStartup #PharmaConsulting #DrugDevelopment
#BiotechFounder #BioArctic #CMC #LifeSciences